A Targeted Agent for Sickle Cell Disease - Changing the Protein but Not the Gene
- PMID: 31199089
- DOI: 10.1056/NEJMe1906771
A Targeted Agent for Sickle Cell Disease - Changing the Protein but Not the Gene
Comment on
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical